Correction to: Effectiveness, Tolerability, and Safety of Belimumab in Patients with Refractory SLE: a Review of Observational Clinical-Practice-Based Studies
- PMID: 30140999
- PMCID: PMC6182622
- DOI: 10.1007/s12016-018-8704-1
Correction to: Effectiveness, Tolerability, and Safety of Belimumab in Patients with Refractory SLE: a Review of Observational Clinical-Practice-Based Studies
Abstract
The following changes are made for this article: (1.) Maddalena Larosa's given name and surname were inadvertently interchanged. The authorgroup section is now corrected. (2.) The author(s)' decision to opt for Open Choice.
Erratum for
-
Effectiveness, Tolerability, and Safety of Belimumab in Patients with Refractory SLE: a Review of Observational Clinical-Practice-Based Studies.Clin Rev Allergy Immunol. 2018 Apr;54(2):331-343. doi: 10.1007/s12016-018-8675-2. Clin Rev Allergy Immunol. 2018. PMID: 29512034 Free PMC article. Review.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
